[Reflux esophagitis. Step-down instead of step-up].
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D004942:Esophagitis, Peptic / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D004945:Esophagoscopy; D018662:Fundoplication; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic; D054328:Proton Pump Inhibitors; D011788:Quality of Life; D064750:Rabeprazole; D013392:Sucralfate / Q000008:administration & dosage / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D064750:Rabeprazole; D013392:Sucralfate